Denintuzumab Biosimilar – Anti-CD19 mAb – Research Grade

Reference:
Size

,

Isotype

IgG1, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameDenintuzumab Biosimilar - Anti-CD19 mAb - Research Grade
SourceCAS 1399672-02-6
SpeciesHumanized
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsDenintuzumab,SGN-19A,SGN-CD19A,hBU12-491,unconjugated:huBU12,CD19,anti-CD19
ReferencePX-TA1348
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Denintuzumab Biosimilar - Anti-CD19 mAb - Research Grade

General information on Anti-CD19[Homo sapiens] (Denintuzumab) Monoclonal Antibody

Denintuzumab has been infestigated in the treatment of Lymphoma, Gliosarcoma, Glioblastoma, Malignant Glioma, Squamous Cell Tumors.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Denintuzumab Biosimilar – Anti-CD19 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CD19 Protein – Human CD19 recombinant protein
Antigen

CD19 Protein – Human CD19 recombinant protein

PX-P4004 250$
CD19 Recombinant Protein
Antigen

CD19 Recombinant Protein

PX-P4077 500$
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

PTX17885 214$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products